IRCT2016110730760N1招募中3 期
Evaluation of topical sylimarin formulation efficacy in prevention of radiodermatitis in breast cancer patients
Vice chancellor for research, Mashhad University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 70 years（—）
- 性别
- Female
入选标准
- •Age above 18 years; Breast cancer patients after mastectomy undergoing radiotherapy; X-ray total dose of 50.4 GY
- •Exclusion criteria: Diabetes; Smoking; Anti inflammatory drugs; Immunosuppressor drugs; Immunodeficiency diseases; Connective tissue diseases
排除标准
- 未提供
研究者
相似试验
已完成
3 期
The treatment of melasma by silymarin creamMelasmaSkin - Dermatological conditionsACTRN12612000602820D Tagreed Altaei100
招募中
3 期
Evaluation of silymarin tablet efficacy in prevention of hepatotoxicity induced by doxorubicin containing chemotherapy regimen in patients with non-metastatic breast cancerIRCT20200408046990N6Mashhad University of Medical Sciences50
招募中
3 期
Evaluating the effect of silymarin oral form on the control of liver toxicity caused by adriamycin and cyclophosphamide drugs in patients with non metastatic breast cancerIRCT2017091136125N1Vice chancellor for research, Mashhad University of Medical Sciences40
已完成
2 期
To evaluate the effectiveness of Silymarin (Livergol) on IL-6 levels and size of endometrioma lesionsIRCT20150905023897N5Vice chancellor for research Tarbiat Modares University60
尚未招募
3 期
Effects of topical gel Silymarin versus placebo as an adjuvant therapy on pain management in patients with painful diabetic neuropathyPainful diabetic neuropathy.Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecifiedE08.40IRCT20120215009014N501Hamedan University of Medical Sciences50